25 September 2025 A new survey from LSIPR reveals that European patent practitioners are grappling with client budget constraints and fast-evolving technologies, with most expecting patenting ...

East IP, in the ‘Highly Recommended’ category, handles trademark work in China for Ticketmaster’s parent company Live Nation ...

8 April 2025 The court hands Edwards Lifesciences a win in its long-running battle with Meril | Panel issues a second Europe-wide injunction over prosthetic heart valve technology | Judges reject ...

As IP plays a more important role in corporate valuations, acquirers are discovering that the biggest risks in life sciences ...

Experts at LSPN North America Fall explore the often-overlooked factors that can make or break transactions, from employee retention strategies to cross-border patent standards.

A panel of experts at LSPN shared how AI is forcing companies to rethink everything from obviousness arguments to the choice between patents and trade secrets, and why the claims filed today may be ...

Hire brings trade secrets and AI litigation expertise from Cooley as firm adds 14th US litigation partner this year. If you ...

Isomorphic Labs' head of IP shares why the first wave of AI-driven drug development stumbled, how data became pharma's most ...

The Japanese pharmaceutical company has filed a cluster of lawsuits against generic drug makers asserting its patent protection and market exclusivity over the high-selling ALS treatment. If you don't ...

Speakers include Raymond Doss, associate general counsel for IP and litigation at Amgen, Reena Bajpai, senior counsel at ...

27 May 2025 Litigation concerns Novartis’ blockbuster $6bn heart failure drug, which has already expired | Indian generic ...